Swog Cancer Research Network

This study is testing whether adding a new drug called amivantamab to standard chemotherapy works better for advanced head and neck cancer that has come back or spread. It is for up to 50 adults whose cancer has progressed after prior immunotherapy. The main goal is to see if thi…

This study directly compares two already-approved drugs, momelotinib and ruxolitinib, for people newly diagnosed with myelofibrosis who also have low blood cell counts. The main goal is to see which drug is better at shrinking an enlarged spleen and reducing the need for blood tr…

This study is testing if adding a new drug called pirtobrutinib to standard chemotherapy works better for treating Richter transformation. Richter transformation is when a slow-growing blood cancer suddenly turns into a much faster-growing and aggressive lymphoma. The trial will …

This study is testing whether adding a specific probiotic (MO-03) to standard immunotherapy drugs helps people with advanced kidney cancer live longer without their cancer getting worse. Researchers believe a healthy gut might make cancer treatments work better. About 718 people …

This study is for people with advanced non-small cell lung cancer that has specific gene changes and has stopped responding to prior treatments. It will test whether two newer targeted drugs, given alone or together, can control the cancer better than standard options. The goal i…

This study is testing an educational coaching program called A-PACT. It aims to help over 1,000 adults with solid cancers have better conversations with their doctors about their care goals and end-of-life wishes. The main goal is to see if this support leads to fewer unplanned h…